0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/ML Injection
RxNorm concept 2751883, clinical drug (scd). Prescribable name: SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Injection, 5y to < 12y.
- RxCUI
- 2751883
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2751883 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Injection, 5y to < 12y
Related concepts
- SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/ML Injection [Comirnaty 2026-2027] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2751883 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2751883 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2751883. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.